Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2022-06-13 Proxy Solicitation & In…
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
02_BOTHE_EGM-20220713_Procuration_FR_vFinal.pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is titled 'PROCURATION' (Proxy) and explicitly details the process for an shareholder to appoint a representative ('mandataire') to attend and vote at an 'assemblée générale extraordinaire' (Extraordinary General Meeting - EGM) scheduled for July 13, 2022. It includes sections for shareholder details, appointing a proxy, the agenda (which covers administrative and capital structure decisions), voting instructions, and quorum rules. This content is characteristic of materials used to solicit shareholder votes and provide necessary information ahead of a general meeting, which aligns directly with the definition of Proxy Solicitation & Information Statement (PSI). It is not the minutes of the meeting (AGM-R), nor is it a general annual report (10-K) or a simple dividend notice (DIV).
2022-06-13 French
02_BOTHE_EGM-20220713_Proxy_EN_vFinal.pdf
Proxy Solicitation & Information Statement Classification · 99% confidence The document is explicitly titled 'PROXY FORM' and details the process for a shareholder to appoint a representative ('proxy holder') to attend and vote at an 'extraordinary general meeting' (EGM) scheduled for July 13, 2022. It includes sections for shareholder details, proxy designation, the agenda for the meeting (including resolutions on capital authorization and registered office transfer), and voting instructions. This content is characteristic of materials used to solicit shareholder votes for a general meeting, which falls under the definition of Proxy Solicitation & Information Statement (PSI). It is not the announcement of the results (DVA), the meeting presentation (AGM-R), or a general regulatory filing (RNS).
2022-06-13 English
03_BOTHE_EGM_20220713_Information droits actionnaires_FR_vFinal.pdf
AGM Information Classification · 96% confidence The document is titled "INFORMATIONS SUR LES DROITS DES ACTIONNAIRES DE POSER DES QUESTIONS A L'OCCASION DE L'ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE" (Information on Shareholders' Rights to Ask Questions at the Extraordinary General Meeting). It details the procedures, deadlines (July 13, 2022 meeting date, June 29, 2022 record date, July 7, 2022 question deadline), and conditions under which shareholders can submit written questions prior to an Extraordinary General Meeting (EGM). This content directly relates to the procedures and information provided to shareholders concerning a general meeting, which aligns best with the definition of Proxy Solicitation & Information Statement (PSI), as it informs shareholders about their rights and procedures related to voting/participation in a meeting. While it mentions the EGM, it is not the final voting results (DVA) nor the general AGM presentation (AGM-R).
2022-06-13 French
BOTHE_PR_2022-06-13_EGM2_EN_vFinal.pdf
AGM Information Classification · 95% confidence The document is a press release dated June 13, 2022, announcing that Bone Therapeutics will hold an 'Extraordinary General Meeting' (EGM) on July 13, 2022. It explicitly states that the 'notice for the extraordinary general meeting, including the agenda' and 'preliminary documents' have been made available. This document is an announcement about an upcoming shareholder meeting and the availability of related materials, rather than the official voting results (DVA) or the full proxy/information statement (PSI). Since it concerns the meeting itself and the materials are being made available, it aligns best with the general category for AGM-related announcements or materials, which is AGM-R (AGM Information), as EGMs are a form of general meeting. Given the focus on the meeting notice and document availability, AGM-R is the most specific fit among the options provided for meeting announcements.
2022-06-13 English
BOTHE_PR_2022-06-13_EGM2_FR_vFinal.pdf
Report Publication Announcement Classification · 98% confidence The document is titled "COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE" (Press Release - Regulated Information) and announces that the company will hold an "Assemblée Générale Extraordinaire" (Extraordinary General Meeting) on July 13, 2022. Crucially, it states that the preparatory documents for this meeting are being made available to the public and shareholders. This structure—a short announcement informing the public that meeting materials (like the agenda, resolutions, and supporting documents) are available—fits the definition of a Report Publication Announcement (RPA). It is not the full AGM presentation (AGM-R) or the proxy materials themselves (PSI), but rather the notice of their availability. Given the document's nature as a regulatory press release announcing the publication/availability of meeting documents, RPA is the most appropriate classification, although RNS is a secondary possibility if RPA were not available. Since RPA is available and fits the 'announcement of report publication' criteria, I select RPA.
2022-06-13 French
BOTHE_20220608_AGO_PV_signed.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "PROCÈS-VERBAL DE L'ASSEMBLÉE GÉNÉRALE ORDINAIRE DU 8 JUIN 2022" (Minutes of the Ordinary General Meeting of June 8, 2022). It details the composition of the meeting, the attendance of shareholders and directors, the agenda (which includes approving annual accounts, remuneration reports, and discharging directors), and the voting results for each resolution. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2022-06-10 French

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.